[Treatment of atrophic osteopathies with sodium fluoride].
D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000698:Analgesia; D001284:Atrophy; D001706:Biopsy; D001842:Bone and Bones / Q000378:metabolism; D002118:Calcium / Q000652:urine; D005260:Female; D005459:Fluorides / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use* / Q000652:urine; D005598:Fractures, Spontaneous / Q000209:etiology; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D008297:Male; D008852:Microradiography; D008875:Middle Aged; D010001:Osteitis Deformans / Q000188:drug therapy*; D010024:Osteoporosis / Q000097:blood / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000652:urine; D011379:Prognosis; D012964:Sodium
D012964:Sodium; D000469:Alkaline Phosphatase; D005459:Fluorides; D006909:Hydroxyproline; D002118:Calcium
Traitement des ostéopathies atrophiques par le fluorure de sodium.